How can a “has-been public chain” that plunged from $52.6 to $4, losing over 85% of its market value, quietly rebound 70% in a month? The answer isn’t retail investors coming back to life—it’s that the project moved the poker table to Washington. On October 16, $INJ surged more than 23% on heavy volume to $9.16, while open interest in perpetual futures jumped by $35 million in just a few days. Moves of this scale usually can’t be explained by sentiment alone.
First, consider the regulatory front. On August 19, an institutional services entity under Injective obtained SEC-registered transfer agent status. This means it can legally record ownership of tokenized securities on-chain and process dividend payments. From September to early October, three institutions—21Shares, Canary Capital, and REX-Osprey—successively filed applications for spot INJ and staking ETFs. Canary even proposed staking 90% of the INJ held by its ETF on-chain. On October 14, co-founder Eric Chen, along with the general counsel and head of policy, visited the White House, the SEC, and the CFTC. On October 15, Canadian-listed mortgage company Pineapple Financial announced it was changing its name to Pentiv and planned to bring a real estate mortgage portfolio worth up to $10 billion onto the Injective chain.
Next, consider the supporting technology. The IIP-709 proposal, currently up for a vote, would switch order placement and cancellation in the exchange module to a fixed gas fee. Retail traders may not notice, but high-frequency market makers can calculate the cost of that friction.
My take is that the core narrative behind this rally has shifted from “a public chain for on-chain derivatives” to “a dedicated chain for institutional RWA.” The ETF applications, SEC status, $10 billion in mortgages moving on-chain, and fixed gas fees all point in the same direction. But bear in mind: ETF applications have been filed, not approved; the $10 billion portfolio is a plan, not a completed migration. When the narrative runs ahead of the facts, volatility often gets ahead of the price, too. During the same period, $ETH traded around 2429, suggesting that the broader market was not providing strong confirmation. The independent run in $INJ depends more on whether its own story can deliver.
The signals really worth watching aren’t the candlesticks, but the review progress of those three ETF applications and whether Pentiv’s mortgage portfolio has actually started moving on-chain.
#Injective #RWA #ETF
First, consider the regulatory front. On August 19, an institutional services entity under Injective obtained SEC-registered transfer agent status. This means it can legally record ownership of tokenized securities on-chain and process dividend payments. From September to early October, three institutions—21Shares, Canary Capital, and REX-Osprey—successively filed applications for spot INJ and staking ETFs. Canary even proposed staking 90% of the INJ held by its ETF on-chain. On October 14, co-founder Eric Chen, along with the general counsel and head of policy, visited the White House, the SEC, and the CFTC. On October 15, Canadian-listed mortgage company Pineapple Financial announced it was changing its name to Pentiv and planned to bring a real estate mortgage portfolio worth up to $10 billion onto the Injective chain.
Next, consider the supporting technology. The IIP-709 proposal, currently up for a vote, would switch order placement and cancellation in the exchange module to a fixed gas fee. Retail traders may not notice, but high-frequency market makers can calculate the cost of that friction.
My take is that the core narrative behind this rally has shifted from “a public chain for on-chain derivatives” to “a dedicated chain for institutional RWA.” The ETF applications, SEC status, $10 billion in mortgages moving on-chain, and fixed gas fees all point in the same direction. But bear in mind: ETF applications have been filed, not approved; the $10 billion portfolio is a plan, not a completed migration. When the narrative runs ahead of the facts, volatility often gets ahead of the price, too. During the same period, $ETH traded around 2429, suggesting that the broader market was not providing strong confirmation. The independent run in $INJ depends more on whether its own story can deliver.
The signals really worth watching aren’t the candlesticks, but the review progress of those three ETF applications and whether Pentiv’s mortgage portfolio has actually started moving on-chain.
#Injective #RWA #ETF